Johnson & Johnson Stock (JNJ) Update: Shares Hold Near $208 as Markets Close for the Weekend; Eczema Trial Halt, Pipeline Wins, and 2026 Outlook in Focus ts2.tech Source link
Eczema injectable drug provides quick itch relief, clinical trial results show Medical Xpress Source link
Eczema Pipeline Drugs Landscape Report 2025: MOA Analysis, R&D Progress, Clinical Trial Pipeline, and Strategic Market Evolution The Globe and Mail Source link
Daily shower or bath does not worsen eczema, finds controlled trial Pulse Today Source link